542771 — Novateor Research Laboratories Cashflow Statement
0.000.00%
- IN₹229.62m
- IN₹239.80m
- IN₹12.07m
Annual cashflow statement for Novateor Research Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | R2022 March 31st | R2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | Interim Report | Interim Report | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 0.266 | 0.173 | -2.28 | 0.367 | 0.463 |
Depreciation | |||||
Non-Cash Items | 0.084 | 0.297 | 0.342 | 0.607 | 0.285 |
Other Non-Cash Items | |||||
Changes in Working Capital | -35.5 | -4.09 | -12.2 | -25.8 | -6.13 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -34.2 | -2.66 | -13.2 | -23.9 | -4.57 |
Capital Expenditures | -0.957 | -0.916 | -15.1 | — | -7.36 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0 | 0 | 0 | 12.4 | -0.134 |
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.957 | -0.916 | -15.1 | 12.4 | -7.5 |
Financing Cash Flow Items | 0.083 | 1.42 | 1.42 | — | -0.286 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 41.8 | 3.22 | 3.49 | 6.86 | 10.7 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 6.67 | -0.351 | -24.8 | -4.71 | -1.33 |